Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Valvular Atrial Fibrillation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04701749
What this trial is testing

Study of the Effects of Anticoagulant Interruption Covered by Percutaneous Left Atrial Occlusion in Patients With Chronic Atrial Fibrillation and Radiation Cystitis at Risk of Bleeding

Who this might be right for
Radiation CystitisNon-valvular Atrial Fibrillation
University Hospital, Clermont-Ferrand 40
Not applicableUnknownNCT04097132
What this trial is testing

Pattern of Non Valvular Atrial Fibrillation in Acute Ischemic Stroke Patients at Assiut University Hospitals

Who this might be right for
Atrial Fibrillation
Assiut University 1
Not applicableStudy completedNCT04249401
What this trial is testing

Study to Gather Information About the Safety of Oral Anticoagulation Drugs and How Well These Drugs Work in Real World for Patients With Non-valvular Atrial Fibrillation (Irregularly Heart Beats Which is Not Caused by a Heart Valve Problem)

Who this might be right for
Atrial Fibrillation
Bayer 134,897
Not applicableStudy completedNCT01855139
What this trial is testing

Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism

Who this might be right for
Atrial Fibrillation
Bayer 106
Post-approval studies (Phase 4)Ended earlyNCT03062319
What this trial is testing

Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis

Who this might be right for
Ischemic StrokeAtrial FibrillationAtherothrombosis
National Hospital Organization Osaka National Hospital 321
Post-approval studies (Phase 4)Study completedNCT01493557
What this trial is testing

A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,067
Not applicableLooking for participantsNCT05654272
What this trial is testing

Development of CIRC Technologies

Who this might be right for
Cardiovascular DiseasesHeart FailureIschemic Heart Disease+7 more
The Cleveland Clinic 1,000
Post-approval studies (Phase 4)UnknownNCT02666157
What this trial is testing

Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
National Cheng-Kung University Hospital 3,672
Post-approval studies (Phase 4)Looking for participantsNCT06187311
What this trial is testing

Clinical Trial to Evaluate Efficacy and Safety of Rivaroxaban 15mg and 20mg in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial FibrillationAnticoagulant Adverse Reaction
Korea University Anam Hospital 940
Not applicableStudy completedNCT02239887
What this trial is testing

Coherex WAVECREST I Left Atrial Appendage Occlusion Study

Who this might be right for
Non-valvular Paroxysmal, Persistent, or Permanent Atrial FibrillationLAA Anatomy Amenable to Treatment by Percutaneous TechniqueAnticoagulation Indication for Potential Thrombus Formation in the Left Atrium
Coherex Medical 155
Post-approval studies (Phase 4)UnknownNCT03234114
What this trial is testing

Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)

Who this might be right for
Acute Coronary Syndrome (ACS)Non-valvular Atrial Fibrillation (NVAF)
The First Affiliated Hospital with Nanjing Medical University 3,746
Large-scale testing (Phase 3)Study completedNCT00403767
What this trial is testing

An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

Who this might be right for
Atrial FibrillationStrokeEmbolism
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 14,269
Not applicableStudy completedNCT03746301
What this trial is testing

Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 924
Not applicableStudy completedNCT03199521
What this trial is testing

Assessment of The Effect of Apixaban in AF

Who this might be right for
Atrial FibrillationEmbolism Thrombosis
East and North Hertfordshire NHS Trust 240
Not applicableStudy completedNCT02663076
What this trial is testing

Factor XA - Inhibition in RENal Patients With Non-valvular Atrial Fibrillation - Observational Registry

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)Chronic Kidney Disease (CKD)
GWT-TUD GmbH 1,700
Not applicableEnded earlyNCT03136510
What this trial is testing

Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban

Who this might be right for
Coagulation DisorderNon Valvular Atrial Fibrillation
Hopital Lariboisière 12
Not applicableStudy completedNCT05804747
What this trial is testing

Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo 1,204
Not applicableUnknownNCT06057467
What this trial is testing

Early Versus Late Initiation of Anticoagulation in Mild-to-moderate AIS Patients With NVAF

Who this might be right for
Acute Ischemic StrokeAtrial Fibrillation
Second Affiliated Hospital, Zhejiang University, School of Medicine 2,351
Testing effectiveness (Phase 2)Study completedNCT00938730
What this trial is testing

A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Astellas Pharma Inc 1,280
Not applicableStudy completedNCT02951039
What this trial is testing

Edoxaban Treatment in Routine Clinical Practice for Patients With Atrial Fibrillation in Korea and Taiwan (ETNA-AF-KOR-TWN)

Who this might be right for
Atrial Fibrillation
Daiichi Sankyo 3,008
Next Page